Posted in | News | Biofuels | Green Energy

Envergent Technologies to Assist High North BioResources in Biomass Renewable Energy Project

Envergent Technologies, a venture of Ensyn and Honeywell’s UOP, declared that High North BioResources Partnership, a joint venture of Ensyn Technologies and Tolko Industries, has chosen the company to carry out an engineering research on converting wood residue into renewable electricity and heat.

The High North power production to be located in Alberta, Canada, will incorporate the Rapid Thermal Processing technology (RTP), a patented expertise of Envergent Technologies, in the manufacture of pyrolysis oil, a light weight and smokeless burning fuel. The RTP technology quickly heats the biomass products such as straw or wood chips in a closed pressure system to produce higher quantity of pyrolysis oil. The oil will be utilized to produce the renewable electricity and to provide heat to a nearby located sawmill possessed by Tolko Industries. The pyrolysis plant will process over 400 bone-dry metric tons of leftover wood of sawmill every day and manufacture pyrolysis oil measuring over 20 million gallons every year. The pyrolysis oil can be utilized in industrial furnaces or burners in the burning process to heat or run electric generators. The plant will also have the potential to manufacture a renewable resin component that has usage in the production of wood panels.

Envergent Technologies will carry out site appraisal activities to make out ways for combining the activities of Tolko saw mill in the project. It will also assist in choosing the equipment set up, technology usage, plant structure evaluation, and program for constructing the RTP unit for the facility.

Source:  https://uop.honeywell.com/en

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.